dc.contributor.author | Soni, A. | |
dc.contributor.author | Wright, N. | |
dc.contributor.author | Agwu, J. C. | |
dc.contributor.author | Timmis, A. | |
dc.contributor.author | Drew, J. | |
dc.contributor.author | Kershaw, M. | |
dc.contributor.author | Moudiotis, C. | |
dc.contributor.author | Regan, F. | |
dc.contributor.author | Williams, E. C. | |
dc.contributor.author | Wan, J. | |
dc.contributor.author | Ng, S. M. | |
dc.date.accessioned | 2022-04-21T09:39:55Z | |
dc.date.available | 2022-04-21T09:39:55Z | |
dc.date.issued | 2022-02-01 | |
dc.identifier.citation | Diabetes Res Clin Pract. 2022 Feb;184:109196. doi: 10.1016/j.diabres.2022.109196. Epub 2022 Jan 13. | |
dc.identifier.pmid | 35033598 | |
dc.identifier.doi | 10.1016/j.diabres.2022.109196 | |
dc.identifier.uri | https://rde.dspace-express.com/handle/11287/622424 | |
dc.description.abstract | Real-time continuous glucose monitoring (rtCGM) and FreeStyle Libre glucose monitoring systems (isCGM) are new evolving technologies used in the management of Type 1 diabetes. They offer potential to improve diabetes control and reduce hypoglycaemia. rtCGM can be linked to insulin pump providing hybrid closed loop therapy. Families of children and young people are keen to have the benefit from these technologies. These are relatively expensive so it is important that health care professionals, families of children and young people (CYP) with diabetes are adequately trained in the use of these devices. Health care professionals need to be able to make patient selection based on individual needs and preferences to achieve maximum benefit. Association of Children's Diabetes Clinicians (ACDC) developed a comprehensive guideline in 2017 to help identify which patients may be most likely to benefit and how these technologies may be practically implemented. Since then new technologies have been introduced and the use of GCM has expanded in routine clinical practice. This article, aims to provide a practical approach and help identify which patients may be most likely to benefit and how the technology may be implemented in order to maximise the clinical benefits. | |
dc.language.iso | eng | |
dc.publisher | Elsevier | |
dc.relation.url | https://linkinghub.elsevier.com/retrieve/pii/S0168-8227(22)00008-0 | |
dc.rights | © 2022 The Author(s). Published by Elsevier B.V. All rights reserved. | |
dc.rights.uri | http://creativecommons.org/publicdomain/zero/1.0/ | |
dc.subject | Adolescent | |
dc.subject | Blood Glucose | |
dc.subject | *Blood Glucose Self-Monitoring | |
dc.subject | Child | |
dc.subject | *Diabetes Mellitus, Type 1/drug therapy | |
dc.subject | Humans | |
dc.subject | Hypoglycemic Agents/therapeutic use | |
dc.subject | Insulin Infusion Systems | |
dc.subject | Children and young people | |
dc.subject | Continuous Glucose Monitoring | |
dc.subject | Technology | |
dc.subject | Time in range | |
dc.subject | Type 1 diabetes | |
dc.title | A practical approach to continuous glucose monitoring (rtCGM) and FreeStyle Libre systems (isCGM) in children and young people with Type 1 diabetes | |
dc.type | Journal Article | |
dc.identifier.journal | Diabetes research and clinical practice | |
dc.description.note | The article is available via Open Access. Click on the 'Additional link' above to access the full-text. | |
dc.type.version | ppublish | |
dc.description.admin-note | Published version, accepted version (12 month embargo), submitted version | |
dc.date.epub | 2022-01-17 | |
dc.citation.volume | 184 | |
dc.citation.spage | 109196 | |